XZXihui Zhou

Xihui Zhou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xihui Zhou has a total of 62 co-authors. Here are the top co-authors by number of shared publications:

  • Li Huang

    Prenatal Diagnostic Center and Cord Blood Bank, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, People’s Republic of China

    3 shared publications
  • Che Zhang

    Department of Pediatrics, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

    2 shared publications
  • Che Zhang

    Department of Pharmacy, South China Hospital, Medical School, Shenzhen University, Shenzhen, Guangdong, China

    2 shared publications
  • Haifeng Geng

    Department of Neonatology, Children’s Hospital of Soochow University

    2 shared publications
  • Huawei Wang

    Department of Neonatology, Children’s Hospital of Soochow University

    2 shared publications
  • Jiaowei Gu

    Department of Pediatrics, Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan, Hubei, People's Republic of China

    2 shared publications

Latest Publications

  • Open Access

    Gut microbiota functional remodeling and butyrate depletion amplify anti-Ro/La antibody-driven type I interferon activation in neonatal lupus

    by Wenqiang Sun, Yihui Li, Xue Liu, Shuyang Yu, Wenmei Li, Huawei Wang, Haifeng Geng, Lili Li, Jinhui Hu, Jie Huo, et al.

    1. Neonatal lupus erythematosus (NLE) is a passively acquired autoimmune disorder resulting from the transplacental transfer of maternal autoantibodies, predominantly antibodies against Ro/Sjögren ...


  • Open Access

    Seizure phenotypes and short-term prognosis in neonatal lupus: a multicenter retrospective cohort in China

    by Wenqiang Sun, Xinyun Jin, Yihui Li, Xue Liu, Linzhou Zhu, Minqian Zhou, Zhirong Xie, Lili Li, Yanliang Yu, Yue Jiang, et al.

    Objectives: Neonatal lupus erythematosus (NLE) is an antibody-mediated autoimmune disorder that can affect neurologic outcomes. Seizures are an uncommon but clinically important phenotype. This study assessed clinical features, neuroimaging findings, and short-term outcomes in infants with NLE and seizures. Methods: We conducted a multicenter retrospective cohort study of infants with NLE admitted to seven tertiary centers in China. Infants were categorized as epileptic seizures (ES), non-epileptic CNS involvement (NE), or no CNS involvement (nCNS). Maternal characteristics and medications during pregnancy, infant clinical manifestations, laboratory indices, autoantibodies, EEG findings, and neuroimaging were extracted from medical records. Group comparisons and multivariable logistic regression were performed to identify factors associated with ES. Follow-up was conducted to 6 months of age. Results: Among 246 infants with NLE, 17 (6.91%) had seizures, 39 (15.85%) had non-seizure CNS involvement, and 190 (77.24%) had no CNS involvement. All ES infants presented with acute symptomatic seizures, predominantly focal. Neuroimaging abnormalities were common, most frequently intracranial hemorrhage. Anti-SSA/Ro positivity was universal in ES cases and significantly higher than in nCNS ( P < 0.05). Maternal hydroxychloroquine (HCQ) use was less frequent in ES than nCNS ( P < 0.05). Regarding organ involvement, the ES group showed higher rates of thrombocytopenia, coagulation abnormalities, hypocomplementemia, and pancytopenia than the nCNS group, as well as higher frequencies of hypocomplementemia and pancytopenia compared with the NE group (all P < 0.05). Multivariate regression analysis revealed that maternal HCQ use during pregnancy was independently associated with a lower odds of ES (OR: 0.066, 95% CI: 0.015–0.288, P = 0.001). No recurrent seizures were observed in neonates in the ES group after hospital discharge. However, nine infants exhibited varying degrees of developmental delay. Conclusions: NLE infants with seizures often exhibit focal seizures and structural brain injury, associated with anti-SSA/Ro positivity, limited maternal HCQ exposure, and hematologic abnormalities. Despite good seizure control, developmental delay was frequent, indicating risk for adverse neurodevelopment.

  • Open Access

    Topical and intravenous administration of human umbilical cord mesenchymal stem cells in patients with diabetic foot ulcer and peripheral arterial disease: a phase I pilot study with a 3-year follow-up

    by Che Zhang, Li Huang, Xiaofen Wang, Xiaoya Zhou, Xiaoxian Zhang, Ling Li, Jieying Wu, Meng Kou, Cheguo Cai, Qizhou Lian, et al.

    Background: Diabetic foot ulcer (DFU) is a serious chronic complication of diabetes mellitus that contributes to 85% of nontraumatic lower extremity amputations in diabetic patients. Preliminary clinical benefits have been shown in treatments based on mesenchymal stem cells for patients with DFU or peripheral arterial disease (PAD). However, the long-term safety and benefits are unclear for patients with both DFU and PAD who are not amenable to surgical revascularization.Methods: In this phase I pilot study, 14 patients with PAD and incurable DFU were enrolled to assess the safety and efficacy of human umbilical cord mesenchymal stem cell (hUC-MSC) administration based on conservative treatments. All patients received topical and intravenous administrations of hUC-MSCs at a dosage of 2 × 105cells/kg with an upper limit of 1 × 107cells for each dose. The adverse events during treatment and follow-up were documented for safety assessments. The therapeutic efficacy was assessed by ulcer healing status, recurrence rate, and 3-year amputation-free rate in the follow-up phase.Results: The safety profiles were favorable. Only 2 cases of transient fever were observed within 3 days after transfusion and considered possibly related to hUC-MSC administration intravenously. Ulcer disclosure was achieved for more than 95% of the lesion area for all patients within 1.5 months after treatment. The symptoms of chronic limb ischaemia were alleviated along with a decrease in Wagner scores, Rutherford grades, and visual analogue scale scores. No direct evidence was observed to indicate the alleviation of the obstruction in the main vessels of target limbs based on computed tomography angiography. The duration of rehospitalization for DFU was 2.0 ± 0.6 years. All of the patients survived without amputation due to the recurrence of DFU within 3 years after treatments.Conclusions: Based on the current pilot study, the preliminary clinical benefits of hUC-MSCs on DFU healing were shown, including good tolerance, a shortened healing time to 1.5 months and a favorable 3-year amputation-free survival rate. The clinical evidence in the current study suggested a further phase I/II study with a larger patient population and a more rigorous design to explore the efficacy and mechanism of hUC-MSCs on DFU healing.Trial registration: The current study was registered retrospectively on 22 Jan 2022 with the Chinese Clinical Trial Registry (ChiCTR2200055885),http://www.chictr.org.cn/showproj.aspx?proj=135888Graphical


  • Open Access

    Pulmonary sequelae of pediatric patients after discharge for COVID‐19: An observational study

    by Che Zhang, Li Huang, Xiaoshi Tang, Yuxin Zhang, Xihui Zhou


  • Open Access

    Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series

    by Che Zhang, Jiaowei Gu, Quanjing Chen, Na Deng, Jingfeng Li, Li Huang, Xihui Zhou

    As of April 18, 2020, over 2,000,000 patients had been diagnosed with coronavirus disease-2019 (COVID-19) globally, and more than 140,000 deaths had been reported. The clinical and epidemiological characteristics of adult patients have been documented recently. However, information on pediatric patients is limited. We describe the clinical and epidemiological characteristics of pediatric patients to provide valuable insight into the early diagnosis and assessment of COVID-19 in children. This retrospective, observational study involves a case series performed at 4 hospitals in West China. Thirty-four pediatric patients with COVID-19 were included from January 27 to February 23, 2020. The final follow-up visit was completed by March 16, 2020. Clinical and epidemiological characteristics were analyzed on the basis of demographic data, medical history, laboratory tests, radiological findings, and treatment information. Data analysis was performed for 34 pediatrics patients with COVID-19 aged from 1 to 144 months (median 33.00, interquartile range 10.00–94.25), among whom 14 males (41%) were included. All the patients in the current study presented mild (18%) or moderate (82%) forms of COVID-19. A total of 48% of patients were noted to be without a history of exposure to an identified source. Mixed infections of other respiratory pathogens were reported in 16 patients (47%). Comorbidities were reported in 6 patients (18%). The most common initial symptoms were fever (76%) and cough (62%). Expectoration (21%), vomiting (12%), and diarrhea (12%) were also reported in a considerable portion of cases. A substantial increase was detected in serum amyloid A for 17 patients (among 20 patients with available data; 85%) and in high-sensitivity C-reactive protein for 17 patients (among 29 patients with available data; 59%), whereas a decrease in prealbumin was noticed in 25 patients (among 32 patients with available data; 78%). In addition, significant increases in the levels of lactate dehydrogenase and α-hydroxybutyrate dehydrogenase were detected in 28 patients (among 34 patients with available data; 82%) and 25 patients (among 34 patients with available data; 74%), respectively. Patchy lesions in lobules were detected by chest computed tomographic scans in 28 patients (82%). Ground-glass opacities, which were a typical feature in adults, were rare in pediatric patients (3%). Rapid radiologic progression and a late-onset pattern of lesions in the lobules were also noticed. Lesions in lobules still existed in 24 (among 32 patients with lesions; 75%) patients that were discharged, although the main symptoms disappeared a few days after treatment. All patients were discharged, and the median duration of hospitalization was 10.00 (8.00–14.25) days. The current study was limited by the small sample size and a lack of dynamic detection of inflammatory markers. Our data systemically presented the clinical and epidemiological features, as well as the outcomes, of pediatric patients with COVID-19. Stratified analysis was performed between mild and moderate cases. The findings offer new insight into early identification and intervention in pediatric patients with COVID-19.


    • 1 May 2020
      • Vol. 22  (5) , 441-445

    咪达唑仑滴鼻用于新生儿磁共振镇静的效果研究——前瞻性单盲随机对照研究

    by Fang-Hui Wang, Jie Zhang, Mi Xiao, Fang Wu, Li Liu, Xi-Hui Zhou

    观察并比较咪达唑仑经鼻吸收与苯巴比妥钠肌肉注射对于新生儿头颅磁共振检查时的镇静效果。 将2017年9月至2019年3月间行头颅磁共振检查的70例新生儿随机分为观察组和对照组,每组35例。观察组给予咪达唑仑滴鼻(0.3 mg/kg),对照组给予苯巴比妥钠肌肉注射(10 mg/kg)。应用改良Ramsay镇静评分表评估新生儿镇静情况;同时比较两组磁共振完成情况及不良反应发生情况。 观察组给药后20 min时镇静评分最高,后逐渐降低,70 min时降至最低;对照组给药后10 min时镇静评分最低,后逐渐增高,40 min、50 min时达最高,再逐渐降低。两组各时间段镇静评分比较,给药后40 min前观察组镇静评分均高于对照组(P < 0.05);40~70 min两组镇静评分比较差异均无统计学意义(P > 0.05)。观察组磁共振检查成功率(89%)高于对照组(69%,P < 0.05)。两组不良反应比较,差异无统计学意义(P > 0.05)。 咪达唑仑滴鼻用于新生儿头颅磁共振检查的镇静效果优于苯巴比妥钠肌肉注射,且快速易行,安全有效。


  • Open Access

    Clinical Characteristics of 34 Children with Coronavirus Disease-2019 in the West of China: a Multiple-center Case Series

    by Che Zhang, Jiaowei Gu, Quanjing Chen, Na Deng, Jingfeng Li, Li Huang, Xihui Zhou

    Background: Up to 9 March, 2020, 109577 patients were diagnosed with coronavirus disease-2019 (COVID-19) globally. The clinical and epidemiological characteristics of adult patients have been revealed recently. However, the information of paediatric patients remains unclear. We describe the clinical and epidemiological characteristics of paediatric patients to provide valuable insight into early diagnosis of COVID-19 in children, as well as epidemic control policy making. Methods and Findings: This retrospective, observational study was a case series performed at 4 hospitals in the west of China. Thirty-four paediatric patients with COVID-19 were included from January 1 to February 25, 2020. And the final follow-up visit was completed by February 28, 2020. Clinical and epidemiological characteristics were analyzed on the basis of demographic data, medical history, laboratory tests, radiological findings, and treatment information. Data analysis was performed on 34 paediatrics patients with COVID-19 aged from 1 to 144 months (median 33.00, IQR 10.00 - 94.25), among whom 14 males (41.18%) were included. 47.60% of patients were noticed without any exposure history. The median incubation period was 10.50 (7.75 - 25.25) days. Infections of other respiratory pathogens were reported in 16 patients (47.06%). The most common initial symptoms were fever (76.47%), cough (58.82%), and expectoration (20.59%). Vomiting (11.76%) and diarrhea (11.76%) were also reported in a considerable portion of cases. A remarkable increase was detected in serum amyloid A for 17 patients (85.00%) and high-sensitivity C-reactive protein for 17 patients (58.62%), while a decrease of prealbumin was noticed in 25 patients (78.13%). In addition, the levels of lactate dehydrogenase was increased significantly in 28 patients (82.35%), as well as α-hydroxybutyrate dehydrogenase in 25 patients (73.53%). Patchy lesions in lobules were detected by chest computed tomographic scans in 28 patients (82.36%). The typical feature of ground-glass opacity for adults was rare in paediatric patients (2.94%). A late-onset pattern of lesions in lobules were also noticed. Stratified analysis of the clinical features were not performed due to relatively limited samples. Conclusions: Our data presented the clinical and epidemiological features of paediatric patients systemically. The findings offer new insight into the early identification and intervention of paediatric patients with COVID-19. Author summary: Why was this study done?: The 2019-novel coronavirus (2019-nCoV) infection has spread worldwide rapidly. Early identification and intervention are necessary for effective epidemic control in both adults and children, however the clinical and epidemiological characteristics of paediatric patients remains unclear. What did the researchers do and find?: We collected and analyzed clinical data of 34 paediatric patients with coronavirus disease-2019 (COVID-19) in 4 hospitals of China from January 1 to February 25, 2020. We described the clinical and epidemiological features of the patients, and focused on the differences in initial symptoms and radiological findings between paediatric patients and adult patients. Distinguished from adult patients, higher incidences of fever, vomiting, and diarrhea were noticed on admission in paediatric cases. Patchy shadows of high density were common in lobules lesions, while the typical features of ground-glass opacity in adults were rare in paediatric cases. A late-onset pattern of lobules lesions was revealed on the basis of chest computed tomographic scans. What do these findings mean?: The specific clinical features in paediatric patients should be paid more attention to, when the physicians are dealing with suspected cases. The epidemiological model in children was characterized with dominant family cluster transmission and extended incubation period, which should be taken into consideration in policy making for epidemic control.


  • Functional analysis of potassium channels in Kv7.2 G271V mutant causing early onset familial epilepsy

    by Juanjuan Wang, Yuan Li, Zhiyan Hui, Min Cao, Ruiming Shi, Wei Zhang, Limeng Geng, Xihui Zhou


  • Open Access

    Site-directed mutagenesis of neonatal convulsions associated KCNQ2 gene and its protein expression

    by Xi-Hui Zhou, Zhi-Yan Hui, Rui-Ming Shi, Hong-Xia Song, Wei Zhang, Li Liu

    Site-directed mutagenesis of neonatal convulsions associated KCNQ2 gene and its protein expression